Not many MPH students get to see the results of their internship work covered in the New York Times, but Danielle Raso was one of the lucky few. The payment models Danielle worked on with the Center for Medicare and Medicaid Innovation (CMMI) in Woodlawn, Maryland were rolled out via an executive order from President Trump on July 10, directing reforms to dialysis and kidney disease treatment.
Since 1972, End Stage Renal Disease (ESRD) has remained unique as the only condition that specifically makes patients eligible for Medicare, and in 2016, care for Medicare beneficiaries with Chronic Kidney Disease and ESRD accounted for $114 billion in total Medicare expenditures. The new models that Danielle worked on shifts financial incentives for providers away from receiving dialysis in dialysis centers and towards in-home dialysis, which is both less expensive and offers a better quality of life for patients. Additionally, the models waive certain Medicare requirements to make kidney disease patient education more available and incentivize providers to facilitate kidney transplants, which are preferred by most patients. The mandatory model released through the rule will affect approximately 50 percent of the country, and many more providers will be able to join the voluntary models.